A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy-Reference-Cited by-同舟云学术

A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy

Published:2010-04 Issue: Volume:1326 Page:174-183
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Bukhatwa Salma,Zeng Bai-Yun,Rose Sarah,Jenner Peter

Funder

GlaxoSmithKline Pharmaceuticals

Libyan Government

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference45 articles.

1. Subcellular distribution of components of the ubiquitin-proteasome system in non-diseased human and rat brain;Adori;J. Histochem. Cytochem.,2006

2. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies;Barrachina;Neurobiology,2006

3. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion;Bulteau;J. Biol. Chem.,2001

4. Impairment of proteasome structure and function in aging;Carrard;Int. J. Biochem. Cell Biol.,2002

5. The proteasome, a novel protease regulated by multiple mechanisms;DeMartino;J. Biol. Chem.,1999

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease;Heliyon;2024-07

2. Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential;Molecular Neurodegeneration;2023-11-11

3. Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson’s disease and examination of its possible etiologies: infectious or autoimmune?;Neurobiology of Disease;2023-10

4. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets;Signal Transduction and Targeted Therapy;2023-09-22

5. Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology;ACS Chemical Neuroscience;2023-08-03